• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

FDA Clears Aidoc's AI Solution for Triage of Cervical Spine Fractures


The platform prioritizes suspected cases to help ensure patients receive a timely diagnosis from a radiologist.


Aidoc today announced that the U.S. Food and Drug Administration (FDA) cleared its artificial intelligence (AI) solution for triage of cervical spine fractures.

The platform prioritizes suspected cervical spine fracture cases in a radiologist’s worklist, helping to ensure that patients receive a diagnosis in a timely manner.

“Our (cervical spine) solution tested the limit of what we could do because of the difficulty in detecting spine fractures due to the variability by which they present,” said Michael Braginsky, M.S., co-founder and chief technology officer of Aidoc.

According to the findings of a study published in the journal Academic Radiology in 2015, radiologists at Mayo Clinic are expected to interpret images every three to four seconds for eight hours a day to meet workload demands.

AI-driven triage can help empower radiologists by helping maintain quality across their workflow, increase confidence in treating patients on time and improve their workflow.

While many fear that AI could one day replace radiologists, the software actually works best in tandem with the radiologist, according to the company.

In fact, the American College of Radiology (ACR) Data Science Institute launched the ACR AI-Lab free software platform to empower radiologists to participate in the creation, validation and use of AI in healthcare.

For Aidoc, this is the Tel Aviv, Israel-based company’s third FDA clearance in the last nine months.

In May, the AI solutions provider for radiologists received clearance for its pulmonary embolism platform, which helps radiologists flag cases of pulmonary embolism in chest CT scans. And last August, Aidoc received clearance for an AI tool that identifies certain hemorrhages based on images of the brain.

Get the best insights in digital health directly to your inbox.


Aidoc Raises $27M for AI Imaging Tool

How AI Is Shaking Up Healthcare, Beyond Diagnostics

AI Algorithm Predicts Risk of FH with High Accuracy

Related Videos
Image: Ron Southwick, Chief Healthcare Executive
George Van Antwerp, MBA
Edmondo Robinson, MD
Craig Newman
© 2024 MJH Life Sciences

All rights reserved.